Dose-Effect Relationship of Botulinum Toxin Type A in the Management of Strabismus: A Review

Botulinum toxin type A (BTXA) is a well-accepted non-surgical therapy for strabismus. However, its dose and technique vary widely. We reviewed published evidence on the dose effect of BTXA in treating various types of strabismus. Articles on BTXA therapy outcomes were reviewed to study doses and bra...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2024-10, Vol.16 (10), p.e71271
Main Authors: Alhejaili, Asrar L, Alkayyal, Aaesha A, Alawaz, Razan A, Alshareef, Esraa K, Al-Habboubi, Hussain
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c1311-e43d1dd3f79e89333d9c73db9891240ee83a8e2849b28d4f8d6368213ebbb3293
container_end_page
container_issue 10
container_start_page e71271
container_title Curēus (Palo Alto, CA)
container_volume 16
creator Alhejaili, Asrar L
Alkayyal, Aaesha A
Alawaz, Razan A
Alshareef, Esraa K
Al-Habboubi, Hussain
description Botulinum toxin type A (BTXA) is a well-accepted non-surgical therapy for strabismus. However, its dose and technique vary widely. We reviewed published evidence on the dose effect of BTXA in treating various types of strabismus. Articles on BTXA therapy outcomes were reviewed to study doses and brands of BTXA used and their efficacy for specific types of strabismus. Researchers indicated that greater dosages may be used safely without increasing the risk of complications. The review suggested a positive dose-response relationship of BTX to success but with a higher risk of complications. No single dose of BTX could be recommended for strabismus management.
doi_str_mv 10.7759/cureus.71271
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3116338064</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3116338064</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1311-e43d1dd3f79e89333d9c73db9891240ee83a8e2849b28d4f8d6368213ebbb3293</originalsourceid><addsrcrecordid>eNpNkDtPwzAUhS0EolXpxow8MpBi-4bYZiulPKQipFI2pMiJb6hRHiVOgP57UloQ0znDp3Okj5BjzkZSXujztK2x9SPJheR7pC94pALFVbj_r_fI0Ps3xhhnUjDJDkkPNGgtFOuTl-vKYzDNMkwbOsfcNK4q_dKtaJXRq6ppc1e2BV1UX66ki_UK6Zh2rVkifTClecUCy2bDPjW1SZwvWn_ZIXP8cPh5RA4yk3sc7nJAnm-mi8ldMHu8vZ-MZ0HKgfMAQ7DcWsikRqUBwOpUgk200lyEDFGBUShUqBOhbJgpG0GkBAdMkgSEhgE53e6u6uq9Rd_EhfMp5rkpsWp93J1EAIpFYYeebdG0rryvMYtXtStMvY45izdK463S-Edph5_sltukQPsH_wqEbw-GcaU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3116338064</pqid></control><display><type>article</type><title>Dose-Effect Relationship of Botulinum Toxin Type A in the Management of Strabismus: A Review</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Alhejaili, Asrar L ; Alkayyal, Aaesha A ; Alawaz, Razan A ; Alshareef, Esraa K ; Al-Habboubi, Hussain</creator><creatorcontrib>Alhejaili, Asrar L ; Alkayyal, Aaesha A ; Alawaz, Razan A ; Alshareef, Esraa K ; Al-Habboubi, Hussain</creatorcontrib><description>Botulinum toxin type A (BTXA) is a well-accepted non-surgical therapy for strabismus. However, its dose and technique vary widely. We reviewed published evidence on the dose effect of BTXA in treating various types of strabismus. Articles on BTXA therapy outcomes were reviewed to study doses and brands of BTXA used and their efficacy for specific types of strabismus. Researchers indicated that greater dosages may be used safely without increasing the risk of complications. The review suggested a positive dose-response relationship of BTX to success but with a higher risk of complications. No single dose of BTX could be recommended for strabismus management.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.71271</identifier><identifier>PMID: 39399280</identifier><language>eng</language><publisher>United States</publisher><ispartof>Curēus (Palo Alto, CA), 2024-10, Vol.16 (10), p.e71271</ispartof><rights>Copyright © 2024, Alhejaili et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1311-e43d1dd3f79e89333d9c73db9891240ee83a8e2849b28d4f8d6368213ebbb3293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,37013</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39399280$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alhejaili, Asrar L</creatorcontrib><creatorcontrib>Alkayyal, Aaesha A</creatorcontrib><creatorcontrib>Alawaz, Razan A</creatorcontrib><creatorcontrib>Alshareef, Esraa K</creatorcontrib><creatorcontrib>Al-Habboubi, Hussain</creatorcontrib><title>Dose-Effect Relationship of Botulinum Toxin Type A in the Management of Strabismus: A Review</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Botulinum toxin type A (BTXA) is a well-accepted non-surgical therapy for strabismus. However, its dose and technique vary widely. We reviewed published evidence on the dose effect of BTXA in treating various types of strabismus. Articles on BTXA therapy outcomes were reviewed to study doses and brands of BTXA used and their efficacy for specific types of strabismus. Researchers indicated that greater dosages may be used safely without increasing the risk of complications. The review suggested a positive dose-response relationship of BTX to success but with a higher risk of complications. No single dose of BTX could be recommended for strabismus management.</description><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNkDtPwzAUhS0EolXpxow8MpBi-4bYZiulPKQipFI2pMiJb6hRHiVOgP57UloQ0znDp3Okj5BjzkZSXujztK2x9SPJheR7pC94pALFVbj_r_fI0Ps3xhhnUjDJDkkPNGgtFOuTl-vKYzDNMkwbOsfcNK4q_dKtaJXRq6ppc1e2BV1UX66ki_UK6Zh2rVkifTClecUCy2bDPjW1SZwvWn_ZIXP8cPh5RA4yk3sc7nJAnm-mi8ldMHu8vZ-MZ0HKgfMAQ7DcWsikRqUBwOpUgk200lyEDFGBUShUqBOhbJgpG0GkBAdMkgSEhgE53e6u6uq9Rd_EhfMp5rkpsWp93J1EAIpFYYeebdG0rryvMYtXtStMvY45izdK463S-Edph5_sltukQPsH_wqEbw-GcaU</recordid><startdate>202410</startdate><enddate>202410</enddate><creator>Alhejaili, Asrar L</creator><creator>Alkayyal, Aaesha A</creator><creator>Alawaz, Razan A</creator><creator>Alshareef, Esraa K</creator><creator>Al-Habboubi, Hussain</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202410</creationdate><title>Dose-Effect Relationship of Botulinum Toxin Type A in the Management of Strabismus: A Review</title><author>Alhejaili, Asrar L ; Alkayyal, Aaesha A ; Alawaz, Razan A ; Alshareef, Esraa K ; Al-Habboubi, Hussain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1311-e43d1dd3f79e89333d9c73db9891240ee83a8e2849b28d4f8d6368213ebbb3293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alhejaili, Asrar L</creatorcontrib><creatorcontrib>Alkayyal, Aaesha A</creatorcontrib><creatorcontrib>Alawaz, Razan A</creatorcontrib><creatorcontrib>Alshareef, Esraa K</creatorcontrib><creatorcontrib>Al-Habboubi, Hussain</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alhejaili, Asrar L</au><au>Alkayyal, Aaesha A</au><au>Alawaz, Razan A</au><au>Alshareef, Esraa K</au><au>Al-Habboubi, Hussain</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dose-Effect Relationship of Botulinum Toxin Type A in the Management of Strabismus: A Review</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2024-10</date><risdate>2024</risdate><volume>16</volume><issue>10</issue><spage>e71271</spage><pages>e71271-</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Botulinum toxin type A (BTXA) is a well-accepted non-surgical therapy for strabismus. However, its dose and technique vary widely. We reviewed published evidence on the dose effect of BTXA in treating various types of strabismus. Articles on BTXA therapy outcomes were reviewed to study doses and brands of BTXA used and their efficacy for specific types of strabismus. Researchers indicated that greater dosages may be used safely without increasing the risk of complications. The review suggested a positive dose-response relationship of BTX to success but with a higher risk of complications. No single dose of BTX could be recommended for strabismus management.</abstract><cop>United States</cop><pmid>39399280</pmid><doi>10.7759/cureus.71271</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2024-10, Vol.16 (10), p.e71271
issn 2168-8184
2168-8184
language eng
recordid cdi_proquest_miscellaneous_3116338064
source Publicly Available Content Database; PubMed Central
title Dose-Effect Relationship of Botulinum Toxin Type A in the Management of Strabismus: A Review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T15%3A23%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dose-Effect%20Relationship%20of%20Botulinum%20Toxin%20Type%20A%20in%20the%20Management%20of%20Strabismus:%20A%20Review&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Alhejaili,%20Asrar%20L&rft.date=2024-10&rft.volume=16&rft.issue=10&rft.spage=e71271&rft.pages=e71271-&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.71271&rft_dat=%3Cproquest_cross%3E3116338064%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1311-e43d1dd3f79e89333d9c73db9891240ee83a8e2849b28d4f8d6368213ebbb3293%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3116338064&rft_id=info:pmid/39399280&rfr_iscdi=true